Centella AsiaticavsRetinaldehyde

The four key triterpenoid saponins—madecassoside, asiaticoside, madecassic acid, and asiatic acid—exert distinct but complementary mechanisms. Madecassoside and asiaticoside are anti-inflammatory: they inhibit NF-κB nuclear translocation and IκB kinase activity, reducing TNF-α, IL-6, and IL-1β production in keratinocytes and dermal cells. Madecassic acid and asiatic acid (the aglycone forms) stimulate type I and III collagen synthesis in fibroblasts by upregulating collagen gene expression and procollagen production. All four compounds promote wound healing by stimulating angiogenesis via VEGF (vascular endothelial growth factor) upregulation, fibroblast proliferation and migration, and extracellular matrix remodeling. Centella extracts also increase superoxide dismutase (SOD) and catalase activity in skin cells, enhancing endogenous antioxidant defense. The triterpenes may modulate TGF-β and Smad signaling. TECA (Titrated Extract of Centella Asiatica) standardizes these actives for consistent clinical efficacy.

Retinaldehyde is converted to retinoic acid by retinaldehyde dehydrogenase (RALDH) in a single enzymatic step within keratinocytes and fibroblasts. This makes it more potent than retinol (which requires alcohol dehydrogenase then RALDH) but less irritating than tretinoin (the active form). The single-step conversion produces a more controlled retinoic acid flux, reducing RAR-mediated irritation while still activating collagen synthesis, normalizing keratinocyte differentiation, and inhibiting matrix metalloproteinases. It uniquely has direct antimicrobial activity against Cutibacterium acnes through disruption of bacterial membrane integrity and interference with bacterial fatty acid metabolism — no other retinoid has this property. Clinically, this dual mechanism addresses both acne pathogenesis and photoaging.